Corporate Presentation and Equity Research Analyst Reports | MediciNova, Inc.

Corporate Presentation and Equity Research Analyst Reports

2025.10.092026.08.22

Corporate Presentation

MediciNova Corporate Presentation – August 2026

Equity Research Analyst Report

Maxim Group – 2Q26 Review & Outlook: Multiple Near-Term Events with Readouts in ALS and Metabolic Disease – August 14, 2026

H.C. Wainwright & Co. – Advancing Dual-Asset Pipeline with Two Key Readouts on the Horizon; 2Q26 Results – August 14, 2026

H.C. Wainwright & Co. – Tipelukast Enters Final Stretch Before Key Phase – May 27, 2026

Maxim Group – Resumption of Coverage Report – March 23, 2026

H.C. Wainwright & Co. – Initiation Report – March 16, 2026

D. Boral Capital – Company Update Report – January 30, 2026

Lucid Capital Markets – Initiation Report – January 5, 2026

D. Boral Capital – Company Update Report – December 8, 2025

D. Boral Capital – Initiation Report – December 4, 2024